405
Original Paper
Cell Physiol Biochem 2008;22:405-412
Accepted: October 08, 2008
Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology
and Biochemistr and Biochemistr and Biochemistr and Biochemistr and Biochemistry
Copyright © 2008 S. Karger AG, Basel
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2008 S. Karger AG, Basel
1015-8987/08/0226-0405$24.50/0
Accessible online at:
www.karger.com/cpb
Influence of Amitriptyline on Eryptosis,
Parasitemia and Survival of Plasmodium Berghei-
Infected Mice
Verena Brand
1*
, Saisudha Koka
1*
, Camelia Lang
1
, Verena
Jendrossek
3
, Stephan M. Huber
1,2
, Erich Gulbins
4
and Florian Lang
1
1
Department of Physiology, and
2
Radiation Oncology, University of Tübingen,
3
Department of
Molecular Cell Biology, University of Essen,
4
Department of Molecular Biology, University of Essen,
*equally contributed to the study and thus share first authorship
Prof. Dr. Florian Lang
Physiologisches Institut der Universität Tübingen
Gmelinstr. 5, 72076 Tübingen (Germany)
Tel. +49 7071 29 72194, Fax +49 7071 29 5618
E-Mail florian.lang@uni-tuebingen.de
Key Words
Malaria Cell volume Phosphatidylserine
Sphingomyelinase Ceramide
Abstract
Plasmodia express a sphingomyelinase, which is ap-
parently required for their development. On the other
hand, the sphingomyelinase product ceramide has
previously been shown to delay parasite develop-
ment. Moreover, ceramide triggers suicidal erythro-
cyte death or eryptosis, characterized by exposure
of phosphatidylserine at the erythrocyte surface and
cell shrinkage. Accelerated eryptosis of infected
erythrocytes is considered to clear infected erythro-
cytes from circulating blood and, thus, to favourably
influence the clinical course of malaria. The present
experiments explored whether the sphingomyelinase
inhibitor amitriptyline or genetic knockout of host acid
sphingomyelinase influence in vitro parasite growth,
eryptosis of Plasmodium falciparum-infected human
erythrocytes, in vivo parasitemia and survival of P.
berghei-infected mice. Phosphatidylserine exposure
was determined by annexin V-binding and cell vol-
ume by forward scatter in FACS analysis. In vitro in-
fection of human erythrocytes increased annexin-
binding, an effect blunted in the presence of
amitriptyline (≥ 50 µM). Amitriptyline did not signifi-
cantly alter intraerythrocytic parasite development but
significantly ( ≥ 1 µM) delayed the increase in
parasitemia in vitro. Most importantly, amitriptyline
treatment (1 mM in drinking water) resulted in a sig-
nificant delay of parasitemia and death of infected
mice. However, upon infection, ceramide formation
was stimulated in both, acid sphingomyelinase knock-
out mice (Smpd1
-/-
) and their wild type littermates
(Smpd1
+/+
). Parasitemia following P. berghei infection
was significantly lower in Smpd1
-/-
than in Smpd1
+/+
mice but did not significantly extend the life span of
infected animals. In conclusion, mammalian and para-
site sphingomyelinase contribute to ceramide forma-
tion during malaria, whereby the parasite sphingo-
myelinase ultimately determines the course of the
infection. Amitriptyline presumably blocks both
sphingomyelinases and, thus, its use might be a novel
strategy to treat malaria.
Introduction
The malaria pathogen Plasmodium expresses a
sphingomyelinase, which appears to be important for